팝업레이어 알림


High Quality affordable global standard Insulin, Insulin Analogs & other Biosimilars (mAbs)

View more
Scroll
UNDBIO DIABETES SOLUTION

Only Korean pharmaceutical company to provide a complete Diabetes care Solution by offering high-quality affordable Insulin, Insulin Analogs to meet the unmet need of diabetes patients.

View more
Research and Development

At UNDBIO our pipeline reflects to drive change to defeat Diabetes, Cancer, and Immunology related diseases. Our scientists are currently working on novel processes to make Insulin, Insulin Analogs, mAbs highly affordable

View more
  • Partnering

    UNDBIO is partnering with Drug-Device companies for Insulin Pump, Pen devices and Continuous Blood Glucose Monitoring System.

    View more
  • Injectable Portfolio

    UNDBIO in Phase-2 will be stepping into Small Volume Parenteral, Large Volume Parenteral (Contrast media) and Extended-release Injectables.

    View more
Contact us

Head Office: 11, Simin-ro 434beon-gil, Uijeongbu-si, Gyeonggi-do, (11796) Republic of Korea
Tel: +82 31 853 6409 Fax: +82 31 852 6409

R&D Center: (Ace Gwanggyo Tower2) 1101-ho, 1286-1, Iui-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, (16229) Republic of Korea
Tel: +82 70 8822 6433 Fax: +82 31 8014 2608

Manufacturing unit: 137-66, Gwahakdanji-ro, Sacheon-myeon, Gangneung-si, Gangwon-do, Republic of Korea

View more